Deals

Arbs earn about 3% a year to wait out Proofpoint's $6.3 billion Varonis buyout

Proofpoint agreed to pay $49.75 a share for Varonis, the stock sits 93 cents under the deal price, plaintiff firms are circling a $63.80 peak, and the private rival in the same category is asking for $20 billion.

Vincent JiangVincent Jiangfour-minute read
Share
Rows of servers in a data hall, the kind of file estate Varonis's software maps
1 / 6Slide 1 of 6
Varonis's software maps where sensitive corporate files sit and who can reach them; Proofpoint is paying $49.75 a share for that franchise.

Proofpoint, the Thoma Bravo-owned security vendor, agreed on October 15, 2026, to buy Varonis, the data-security software maker, for $49.75 a share in cash, a transaction worth about $6.3 billion, with the Varonis+0.31% — Varonis, up 0.31 percent today board approving unanimously 1. Close is expected in the first half of 2027, subject to shareholder and regulatory approvals 1.

Thoma Bravo committed the equity and secured debt financing, and Ontario Teachers' Pension Plan agreed to invest into Proofpoint alongside 1. Proofpoint is paying 8.4 times trailing revenue and 53 times trailing free cash flow for a company whose second-quarter revenue grew 18.3% to $180.02 million, with adjusted earnings of $0.04 a share beating the $0.01 consensus 12.

Growth re-accelerated to 18.3% in the quarter Proofpoint priced

$0M$50M$100M$150M$200MQ2 '24Q4 '24Q2 '25Q4 '25Q2 '26$180.02M
Data
Revenue
Q1 '24$114.02M
Q2 '24$130.35M
Q3 '24$148.07M
Q4 '24$158.51M
Q1 '25$136.42M
Q2 '25$152.16M
Q3 '25$161.58M
Q4 '25$173.37M
Q1 '26$173.13M
Q2 '26$180.02M
Revenue in millions of US dollars from Varonis's SEC filings, retrieved October 30, 2026. Growth re-accelerated in 2026 after a slowdown in the second half of 2025, the trend Proofpoint is buying at 8.4 times trailing revenue.9

The premium math exposes the leak. $49.75 is 52% above the $32.71 close on June 22, the last day before the first sale rumors, but only 17% above the $42.35 close on September 1, the day before "additional media reports speculating about a potential sale" 1. The stock added just 2.5% in after-hours trading when the agreement surfaced on October 15 4. The deal was priced before most of the public could act on it.

The spread

Varonis closed at $48.89 on October 22, the day it told noteholders about the merger 3, and traded at $48.82 by October 29, 93 cents under the cash price 4. That is a 1.9% gross spread; with closing roughly eight months out at the back edge of the guided window, the annualized return works out to about 2.9% 4. Short interest sits at 5.51% 4. Waiting through a shareholder vote and regulatory clearances for under 3% a year is pocket change, not payment 4.

The deal price sits $14.05 below this year's high, 93 cents above the tape

02040608052-week high$63.80Deal price$49.75Market, Oct 29$48.82
Data
Value
52-week high$63.80
Deal price$49.75
Market, Oct 29$48.82
US dollars per Varonis share. 52-week high as cited by Wohl & Fruchter's investigation; deal price from the merger announcement of October 15, 2026; market price is the October 29 close.1,3,4

Noteholders get paid only on closing

A October 22 notice to holders of the 1.00% convertible senior notes due 2029 says the merger will constitute a Fundamental Change, a Make-Whole Fundamental Change and a Corporate Event "as of the Effective Time," and that if the merger "is not consummated for any reason, then none" of the three events will have occurred 5. In plain terms, the make-whole protection pays only on closing. The note spread and the equity spread carry the same condition: no close, no pay.

The two camps on price

Halper Sadeh LLC, an investor rights law firm, is investigating whether the board obtained the best possible price, ran a fair process and disclosed everything shareholders need 6. Wohl & Fruchter is questioning the price against the stock's 52-week high of $63.80 3.

The board's answer is on the record: an independent committee ran "extensive outreach to a range of potential strategic and financial buyers," and CEO Yaki Faitelson called the price "immediate, significant, and certain value well in excess of the risk-adjusted value" of the standalone plan 1.

The category reprices while the deal waits

Cyera~$3B — Cyera, private, latest valuation ~$3B, the private company selling data security for the AI age in the same category as Varonis, added a $400 million Goldman Sachs extension to its Series G on September 22, on top of a $600 million round led by Evolution Equity Partners in June 78. Six outlets reported this week that Cyera is in talks at a $20 billion valuation, a figure no company filing confirms 8.

Proofpoint is locking the category's public benchmark at 8.4 times revenue while its closest private rival asks for 67% more than the $12 billion mark Goldman−2.68% — Goldman, down 2.68 percent today underwrote a month earlier 178. Every dollar of credibility the Cyera ask gains is a dollar of ammunition for the firms arguing $49.75 is light 178. The Inference followed the money into Cyera when Goldman wired its check in September; this week's reported repricing is what is new.

Cyera raised $1.4 billion in three 2026 checks before this week's $20 billion ask

$0M$200M$400M$600MSeries F, Jan 2026Series G, Jun 2026Goldman extension, Sep 2026Talks now reported near $20B,unconfirmed
Data
Amount raised
Series F, Jan 2026$400M
Series G, Jun 2026$600M
Goldman extension, Sep 2026$400M
Millions of US dollars, announced by the company. Series F January 2026, Series G June 2026 led by Evolution Equity Partners, and the Goldman Sachs Growth Equity extension of September 2026. The $20 billion figure is reported talks only, unconfirmed by any filing.7,8

What decides it from here

Varonis reports third-quarter results after the close on November 3, with no earnings call because of the pending deal 1. The proxy for the special meeting has not been filed yet 5. Three readings set the spread from here: the Q3 print, the litigation disclosures in the proxy, and whether Cyera's talks close anywhere near $20 billion 8. If the category re-rates, the $49.75 print ages badly and the litigants gain leverage 8. If the Cyera talks die, the deal closes as signed and arbs keep their 3% 8.

Get Deals by email, free

The acquisitions, rounds and contracts that move AI money. In our daily email, every weekday.

Loading GS

Reader comments

0 comments

    Deals

    Anthropic IPO frees 45% of employee stock in two windows; the rest waits on 60-day preset plans

    Two days before Anthropic prices 825 million shares at up to $1.4 trillion, its insider-supply calendar is finally knowable: 45% of employee stock sells in two windows, and the rest only on preset plans no one can change on a headline.

    Deals

    Generac's fourth 2026 acquisition, a Johannesburg power plant, cost R220 million, seller enX says

    The purchase appears only as an eight-line note in Generac's 10-Q; the R220 million price surfaced in the seller's JSE statement. It is the fourth buy of 2026 as Generac races to serve a $4.5 billion data-center backlog.

    Deals

    Tempus AI's $1.9 billion Personalis buy heads to a Nov 30 vote, paid in Tempus stock with up to half in cash

    The $1.9 billion Personalis deal goes to a shareholder vote on November 30 with regulatory review already closed, and the filing shows Tempus pays in its own stock with up to half in cash, against $854 million on its balance sheet.

    Deals

    Veritone bought 30 days with 1.6 million shares as its $40 million Blue Torch loan waits on $25 million

    The AI software company stretched its convertible maturity 30 days and conditioned a $40 million loan on up to $25 million more from its largest stockholders, while revenue fell 30%. The dilution lands on common shareholders either way.

    Deals

    Palo Alto in talks to pay about $500 million for Clutch Security, near 50 times recurring revenue

    Palo Alto Networks is reported in talks to pay about 50 times Clutch Security's recurring revenue, days after CEO Nikesh Arora explained why he pays up for category winners. Wednesday's results release is where such deals have landed before.

    Deals

    AMD issued 14,978,322 shares, about $547 apiece, to close its $8.2 billion World Labs buy

    The filing prices each share AMD handed over at about $547, more than the $534.06 the stock fetched on closing day. What those shares bought is a world model that opened to everyone last week with no paper, no model card and no published price.

    Subscribe to TheInference for free